תבנית:תרופה/פרוטין 30 - Parotin 30
× ×ª×× × ×ª×¨×פ×
×××¨×©× 
| ××× ×× ×× × ×ספ×× | |
|---|---|
| ×§×××¦× ×¤×¨××§×××××ת (ATC4) | |
| ×ר××× ×¤×¢×× (ATC5) | *Paroxetine AS HYDROCHLORIDE 30MG âN06AB05
|
| צ×רת ××ª× | PER OS |
| צ×רת ××× ×× | TABLETS |
| ×ת×××× | Treatment of symptoms of depressive illness of all types including depression accompanied by anxiety. Treatment of symptoms and prevention of relapse of obsessive compulsive disorder (OCD). Treatment of symptoms and prevention of relapse of panic disorder with or without agoraphobia.Treatment of symptoms of social phobia. Post traumatic stress disorder. Generalised anxiety disorders.
|
| ת×× ×ת:× ×ª×× × ×¡×/תר×פ×/פר×××× 30 - Parotin 30 | |
| ×ת××ת ××× ×× | Posology and method of administration |
| ×ת××××ת × ×× | Contraindications |
| ת×פע×ת ××××× | Undesirable effects |
| ת××××ת ××× ×ª×¨×פת××ת | Interaction with other medicinal products and other forms of interaction |
| ש×××ש ×××ר××× ××× ×§× | Pregnancy and Lactation |
| פר××§×××× ×××§× | Pharmacodynamic Properties |
| פר××§××§×× ×××§× | Pharmacokinetic Properties |
| ×¢××× ×ר××¤× ××××ר×ת ××¢××× | |
| ×¢××× ×צר×× | *×¢××× ×צר×× |
|---|
| ער××× ×××××§×רפ××× | ער××× ×§×©×ר×× ×××××§×רפ××× |
|---|---|
| פר×××× 30 ® ××××ר ××©×¨× ××ר×××ת |
| ××פ×ש ×××ר×× | - |
|---|---|
| ××××¢ ×רשת | - |
| ×©× ××¦×¨× | CTS CHEMICAL INDUSTRIES LTD |
| ×©× ××¢× ×ר×ש×× | CTS CHEMICAL INDUSTRIES LTD |
| ר×ש××× | ת×ר×× ××ש×: 06/2004. ר×ש××× ×ת×ר××: 09/2010 |
| ת×ר×× ×¢×××× ××ר×× | 15/10/18 |
××£ ×× × ×צר ×¢× ××× ××× ×××××ר ת×× ×ת ×¢× ×¤×¨×× ×תר×פ×.
- ××£ ×תר×פ×: פר×××× 30 - Parotin 30
- ××ר××¡× ××× ×ת ×©× ×¤×¨×× ×תר×פ×: × ××ª× ×ער×× ×ת ××£ ×תר××¤× ××¢××. ×××××× ×××××¤× ×ת:
{{תר×פ×/פר×××× 30 - Parotin 30}}
×:
{{תר×פ×/פר×××× 30 - Parotin 30
| ×©× ×פר××ר=×¢×¨× ××ש (××רס ×ת ××¢×¨× ×©×××× ××××ר)
}}
השינוי האחרון נעשה בֹ־14 באוקטובר 2018 ב־21:03